Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
BrightView Holdings
BV
$1.37B
| $117K | ﹤0.01% |
16,358
-33
| -0.2% | -$237 |
|
2552
SES AI
SES
$391M
| $116K | ﹤0.01% |
47,834
-46
| -0.1% | -$112 |
|
2553
Coherus Oncology, Inc. Common Stock
CHRS
$151M
| $112K | ﹤0.01% |
26,392
-27
| -0.1% | -$115 |
|
2554
Erasca
ERAS
$448M
| $112K | ﹤0.01% |
40,745
+79
| +0.2% | +$218 |
|
2555
Butterfly Network
BFLY
$390M
| $112K | ﹤0.01% |
48,598
+55
| +0.1% | +$127 |
|
2556
Scholar Rock
SRRK
$3.04B
| $108K | ﹤0.01% |
14,259
-27
| -0.2% | -$204 |
|
2557
First Bank
FRBA
$420M
| $106K | ﹤0.01% |
+10,235
| New | +$106K |
|
2558
ATAI Life Sciences
ATAI
$982M
| $105K | ﹤0.01% |
61,395
-113
| -0.2% | -$194 |
|
2559
Blink Charging
BLNK
$117M
| $105K | ﹤0.01% |
17,555
+18
| +0.1% | +$108 |
|
2560
Sight Sciences
SGHT
$195M
| $103K | ﹤0.01% |
12,369
-92,350
| -88% | -$767K |
|
2561
Ribbon Communications
RBBN
$708M
| $102K | ﹤0.01% |
36,449
+268
| +0.7% | +$746 |
|
2562
Mersana Therapeutics
MRSN
$34.3M
| $101K | ﹤0.01% |
1,225
-1
| -0.1% | -$82 |
|
2563
SIGA Technologies
SIGA
$601M
| $100K | ﹤0.01% |
19,821
-131,224
| -87% | -$662K |
|
2564
Future Fuel
FF
$173M
| $98.7K | ﹤0.01% |
11,159
-14
| -0.1% | -$124 |
|
2565
Angi Inc
ANGI
$814M
| $97.9K | ﹤0.01% |
2,971
| – | – |
|
|
AMRS
2566
DELISTED
Amyris Inc.
AMRS
| $96.2K | ﹤0.01% |
92,949
-157
| -0.2% | -$162 |
|
2567
Microvast
MVST
$835M
| $95.3K | ﹤0.01% |
59,751
-174
| -0.3% | -$278 |
|
2568
Clarus
CLAR
$141M
| $93.3K | ﹤0.01% |
10,195
-36
| -0.4% | -$329 |
|
2569
Nuvation Bio
NUVB
$1.33B
| $92.3K | ﹤0.01% |
51,410
-87
| -0.2% | -$156 |
|
2570
Rimini Street
RMNI
$415M
| $89.4K | ﹤0.01% |
18,653
-90
| -0.5% | -$432 |
|
|
CANO
2571
DELISTED
Cano Health, Inc.
CANO
| $86.8K | ﹤0.01% |
622
+1
| +0.2% | +$140 |
|
2572
CI&T Inc
CINT
$705M
| $84.5K | ﹤0.01% |
+13,550
| New | +$84.5K |
|
|
AGEN
2573
Agenus
AGEN
$137M
| $81.2K | ﹤0.01% |
2,544
-46
| -2% | -$1.47K |
|
2574
1-800-Flowers.com
FLWS
$321M
| $79.6K | ﹤0.01% |
10,203
-2
| -0% | -$16 |
|
|
NSTG
2575
DELISTED
NanoString Technologies, Inc.
NSTG
| $78.2K | ﹤0.01% |
19,334
-22
| -0.1% | -$89 |
|